Airsupra Rescue Inhaler Reduces Risk of Severe Asthma Exacerbations
AstraZeneca’s inhaled anti-inflammatory rescue medication demonstrated significant benefit compared to albuterol in a phase IIIb trial.
Tag: albuterol
All
Latest
Airsupra Rescue Inhaler Reduces Risk of Severe Asthma Exacerbations
AstraZeneca’s inhaled anti-inflammatory rescue medication demonstrated significant benefit compared to albuterol in a phase IIIb trial.
Read More
Ritedose Donates 1 Million Doses of Respiratory Medications to NonprofitÂ
Ritedose Pharmaceuticals is donating 1 million doses of albuterol sulfate and levalbuterol inhalation solutions to Dispensary of Hope, supporting low-income and chronically ill patients.
Read More
FDA Approves Amphastar’s Generic Albuterol Sulfate
The FDA approved Amphastar’s abbreviated new drug application for its albuterol sulfate inhalation aerosol, a generic for Teva’s ProAir HFA.
Read More
FDA-approved Anti-inflammatory Rescue Inhaler for Asthma Now Available
The inhaler contains a short-acting beta2-agonist to help relax the smooth muscles of the airways and an inhaled corticosteroid to help decrease inflammation in the lungs, treating both symptoms and inflammation.
Read More
Cipla Recalls Six Batches of Albuterol Sulfate
The recall is due to a container defect that may result in failure to deliver the recommended dose.Â
Read More
Albuterol Shortage Worsens in US
A nationwide shortage of albuterol is expected to worsen after a US-based pharmaceutical company shuttered its business in February.
Read MoreSchool Staff Fear Liability Over Stock Albuterol
School administrators and prescribing clinicians fear liability in prescribing and administering stock inhalers to students — even in states with strong stock inhaler/albuterol laws.
Read More
Albuterol + Budesonide Cut Risk of Asthma Exacerbation by 27%
Two combinations of albuterol and budesonide used as a rescue medication demonstrated a statistically significant reduction in the risk of a severe exacerbation in patients with moderate to severe asthma.
Read MoreFDA Approves First Generic Albuterol Sulfate
The drug is approved to treat or prevent bronchospasm in patients four and older with reversible obstructive airway disease, and to prevent exercise-induced bronchospasm in patients four and older.
Read More
Reduced Inhaler Use Safe for Infant Bronchiolitis
Researchers from Children’s Hospital of Philadelphia reduced albuterol use for children with bronchiolitis without compromising care, according to research published in Pediatrics.
Read More
FDA Expands Approval of ProAir RespiClick to Children 4 to 11
Teva’s ProAir RespiClick (albuterol sulfate) Inhalation Powder is approved to treat bronchospasm in children 4 to 11 years of age with asthma and prevent exercise-induced bronchospasm.
Read More
FDA Announces Voluntary Recall of Mislabeled Albuterol
Single use vials of 0.083% albuterol sulfate inhalation solution, 3 mL in 25, 30, and 60 unit dose vials were embossed with the wrong concentration.
Read More
Pharmacological Treatment of Respiratory Disorders (2007)
Respiratory therapists are often some of the few resources to offer expert help in finding alternative respiratory medications for patients who experience side effects.
Read More
Albuterol sulfate inhalation solution
Nephron Pharmaceuticals Corp
Read More